• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Session Name:

  • P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 16 - 17 of 17

  • Page:
  • 2
  • 3
  • 4

Clinical Characteristics and Treatment Outcomes in Anti-CD20-treated Multiple Sclerosis Patients Who Switch to Natalizumab: A Komodo Health Sentinel Database Study

Author:Calkwood, Jonathan   English, Jeffrey   Lay, Harry   Long, Daniel   Mao-Draayer, Yang   Riley, Claire   Shoemaker, Thomas   Zhovtis Ryerson, Lana   Belviso, Nicholas   England, Sarah   Rutledge, Danette   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.016  

Author Institution:Minnesota Center for Multiple Sclerosis, Plymouth, MN  Atlanta Neuroscience Institute, Atlanta, GA  Raleigh Neurology Associates, Raleigh, NC  Neuroscience Group, Appleton, WI  Oklahoma Medical Research Foundation, Oklahoma City, OK  Columbia University Medical Center, New York, NY  Rush University Medical Center, Chicago, IL  Jersey Shore University Medical Center, Neptune City, NJ  Biogen, Cambridge, MA  

  • View Abstract
  • View Disclosure

Long-term Ofatumumab Treatment Over 6 Years Did Not Increase the Risk of Serious Infections

Author:Wiendl, Heinz   Meuth, Sven   Pardo, Gabriel   Zamvil, Scott   Boer, lbolya   Bhatt, Alit   Wu, Min   Hu, Xixi   Jehl, Valentine   Sullivan, Roseanne   Montalban, Xavier   Cohen, Jeffrey   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.017  

Author Institution:Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany, Muenster, Germany  Department of Neurology, Medical Faculty, Heinrich-Heine-University, Dusseldorf, Germany, Duesseldorf, Germany  Oklahoma Medical Research Foundation, OK, USA, Oklahoma City, OK  Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, Morristown, NJ  Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ  

  • View Abstract
  • View Disclosure

Displaying 16 - 17 of 17

  • Page:
  • 2
  • 3
  • 4

© 2015 Mira Smart Conference | http://www.mirasmart.com